Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Genentech Says Phase III IMpower010 Study Evaluating Tecentriq Met Primary Endpoint Of DFS At Interim Analysis


RTTNews | Mar 22, 2021 02:05AM EDT

02:04 Monday, March 22, 2021 (RTTNews) - Genentech Says Phase III IMpower010 Study Evaluating Tecentriq Met Primary Endpoint Of DFS At Interim Analysis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC